<unk>  is a Platelet aggregation inhibitor that is FDA approved for the prophylaxis of cardiac ischemic complications in patients undergoing percutaneous coronary intervention and in patients with unstable angina not responding to conventional medical therapy when percutaneous coronary intervention is planned within 24 hours.   Common adverse reactions include chest pain, hypotension, injection site pain, abdominal pain,nausea, vomiting, bleeding, backache.
Abciximab
Picloxydine
Ticlopidine
Pitavastatin
Iotalamic acid
Eptifibatide
Dabigatran
Ticlatone